Dr. Robert Darnell (left), CEO of the New York Genome Center, and Dr. Ajay Royyuru, Director of the IBM Computational Biology Center (right) discuss how IBM's Watson will be used to make sense of vast amounts of genetic sequencing data and medical information to identify personalized treatments for cancer patients, at an event at the New York Genome Center in New York City on March 19, 2014. IBM and NYGC will soon begin testing a Watson prototype designed specifically for genomic research to help oncologists deliver unique, customized cancer treatments according to an individual patient's DNA. (Photo Credit: Jon Simon/Feature Photo Service for IBM.) For more information: Christine Vu, IBM Communications, 415-794-2356
This media asset is free for editorial broadcast, print, online and radio use. It is restricted for use for other purposes.